sar444245
Showing 1 - 1 of 1
Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)
Not yet recruiting
- Squamous Cell Carcinoma
- +2 more
- SAR444245
- Cemiplimab
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022